The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Bristol Myers Squibb announced that OpdualagTM (nivolumab and relatlimab-rmbw), a new, first-in-class, fixed-dose combination of nivolumab and ...
read more
AstraZeneca's Evusheld (tixagevimab co-packaged with cilgavimab), a long-acting antibody combination, has been granted marketing authorization in the ...
read more
Novo Nordisk announced that it is extending its product offerings to better support Canadians living with hemophilia A, as both ESPEROCT® (...
read more
Bristol Myers Squibb announced that the European Commission (EC) has approved Opdivo (nivolumab) in combination with fluoropyrimidine- and platinum-...
read more
The Precision Cancer Consortium (PCC) announced its formation as a new collaboration of pharmaceutical companies with a shared vision of enabling ...
read more
Wednesday, April 20, 2022
Thermo Fisher Scientific has opened its new single-use technology manufacturing site in Ogden, Utah.
read more
Wednesday, April 20, 2022
Labcorp is collaborating with Xcell Biosciences, Inc. to advance critical work that helps clients effectively bring innovative cell and gene therapies...
read more
Legend Biotech Corporation announced the achievement of a $50 million milestone under its collaboration agreement with Janssen Biotech, Inc.
read more
Terran Biosciences, Inc. has entered into an agreement with Sanofi S.A. for worldwide exclusive rights to develop and commercialize two late-stage CNS...
read more
Direct Biologics announced that the FDA has approved the company to proceed with its Phase 3 clinical trial using its investigational EV drug, ExoFlo,...
read more
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has entered into an evaluation and option agreement with Merck to grant them a sole license to evaluate...
read more
RedShift BioAnalytics announces the launch of Apollo, the company’s latest system using ground-breaking MMS technology.
read more
Stealth BioTherapeutics Corp announced that the US Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug ...
read more
Novartis announced the US Food and Drug Administration (FDA) has granted accelerated approval for Kymriah® (tisagenlecleucel) for the treatment of ...
read more
Sandoz announced the launch of a new global initiative called ‘Act4Biosimilars’ to help address health inequity and inequality worldwide.
read more